Andersons pediatric cardiology 2363
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (98.89 KB, 3 trang )
Lymphatics,abnormal,Fontanfailurewith,1345
Lymphoproliferativedisorders,followingcardiactransplantation,1225t,1237–
1238,1237f,1237t
M
Magneticresonanceangiography,320t–321t
contrast-enhanced,323,324f
Magneticresonanceimaging(MRI),318
ofanomaliesoftheaorticarch,891
ofanomalousaorticoriginofacoronaryartery,874
cardiac,inarrhythmias,358
incardiactumors,968,969f
infetalheart,88–90
Kawasakisyndromeand,986–987,987f
normallate-gestationhumanfetalcirculationby,116–117,117t,118f
withpacemakers,373
forpulmonaryhypertension,1387–1388
techniquesfor
assessingfetalcirculatoryphysiology,112
cinephasecontrast,112,113f–114f
magneticresonanceoximetryas,112–114,114f–117f
Malabsorption,growthand,1496
Malformations,associated,15–16
Malnutrition,1495–1503,1496t–1497t
Mannosidosis,cardiacinvolvementin,1092
Mapping,359–360,361f
activation,oftachycardia,360
electroanatomic,oftachycardia,360,362f
Marfansyndrome
cardiacinvolvementin,1077–1078,1078b,1099–1101,1099f,1100t,1100b
inpregnancy,1447
systemicarterialdysfunctionand,1373
Maroteaux-Lamysyndrome,cardiacinvolvementin,1091
Maskedhypertension,1122
MAT,Multifocalatrialtachycardia
Maternalrights,ethicalissuesand,1468
Matrix-arraytransducers,forechocardiography,309
Matrixmetalloproteinase,1356
Maximalplasmadrugconcentration,1429
Maximalvoluntaryventilation,385
McArdledisease,cardiacinvolvementin,1089
McNemarchi-squaretest,414
MCS,Mechanicalcirculatorysupport
Meanpressuregradient,echocardiographicmeasurementsof,306,306f
Mechanicalcirculatorysupport(MCS),1474
chronic,1205–1216
long-term,currentdevicesfor,1208–1210
BerlinHeartEXCORin,1208,1208f
continuousflowventricularassistdevicesin,1209
futuredevicesand,1210
HeartMateIIin,1209
HVADin,1209–1210
totalartificialheartin,1208–1209
managementof,inFontanpathway,1293–1294
short-term,currentdevicesfor,1206–1208
Mechanicalsupport
asbridgetotransplantation,1224f,1227,1227f–1228f
choiceandmodeof,1186,1186t
complete,1186–1187
partial,1187–1188
weaningfrom,1190–1191
Mechanicalvalves,221–222,221f
Mechanicalventilation,managementof,inFontanpathway,1290
Media,1355
Medicalcosts,incongenitalheartdisease,185–187
ofdirectmedicalcare,185,186f,187t
higher,factorsassociatedwith,amongpeoplelivingwith,185–187
reductionof,opportunitiesfor,187
variationin,187
Medicaldecision-making,conceptsrelatedto,1469t
Medicalhome,primary,1483
Medicalproblems,confusionaboutwhomtodiscusswith,parentalconcerns,
1490,1490f
Medicalreadiness,forinterstagemanagement,1308–1309
Medicaltherapy,forcancertherapy-relatedcardiotoxicity,1172
MedtronicMelodyTPV,259
MELAS,arterialdysfunctionand,1375
Menorrhagia,inKawasakisyndrome,994–995
Mentalhealth
incomplexcongenitalcardiacdisease,1406
maternal,1456
Meropenem,forbloodculture-negativeendocarditis,1054t
Mesoderm,33,34f
Meta-analyses,418–419
Metabolicsyndrome,riskfactorclusteringand,433–434
Metabolism,1429
incardiopulmonarybypass,232
cellular,379–381,381f
Metallicvalvutome,1035,1036t
Methylmalonicacidemia,cardiacinvolvementin,1097
Metrics,forinterstagemanagement,1307–1308
MetropolitanAtlantaCongenitalDefectsProgram,180
